Le Lézard
Classified in: Science and technology
Subject: SVY

Ipsos poll reveals how people are using generative AI, and for what


New Ipsos report & webinar reflects on three big ways that brands can use generative AI technology to scale, while still keeping human intelligence at the heart of the process

NEW YORK, April 15, 2024 /PRNewswire/ -- There are three big ways brands can use generative AI to scale and they're not experimental, they're real and available today. That's what Ipsos, one of the world's leading market research companies, revealed via new research and perspectives in its new Insights to Activate report: Gen AI from Wow to How.

One of the tasks that generative artificial intelligence is best at is coming up with a lot of ideas nearly instantly, helping brands ideate new products quickly and efficiently. It's been a notable early use case: One in four generative AI users (25%) say they have used the tools for brainstorming, according to a March 2024 Ipsos poll.

Crunching and summarizing large sets of data is one of the first (and clearest) uses of generative AI, and one of the most common. One in four AI users have used the tools for summarizing complex subjects (23%) or organizing data (22%), according to the Ipsos poll.

The April edition of Ipsos' new Insights to Activate series explores further insights on generative AI and the value of human intelligence through an exclusive report, "Gen AI: From Wow to How" and a companion webinar on April 17 featuring experts from Adobe, the Estée Lauder Companies and New York University. The webinar will explore:

On April 23, Ipsos will release the final piece of its Insights to Activate generative AI campaign: an impact story showcasing how Ipsos leveraged human and artificial intelligence to bring consumer insights to life at Purina.

With commentary from the industry's brightest minds and data-driven thought leadership on the most pressing business questions, monthly releases of Ipsos' Insights to Activate series will explore the forces redefining everything from the election to brand to ESG to Ipsos Global Trends ? giving you the information you need to make better decisions today and tomorrow.

ABOUT IPSOS

Ipsos is one of the largest market research and polling companies globally, operating in 90 markets and employing over 20,000 people.

Our passionately curious research professionals, analysts and scientists have built unique multi-specialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. Our 75 solutions are based on primary data from our surveys, social media monitoring, and qualitative or observational techniques.

Our tagline "Game Changers" sums up our ambition to help our 5,000 customers move confidently through a rapidly changing world.

Founded in France in 1975, Ipsos has been listed on the Euronext Paris since July 1, 1999. The company is part of the SBF 120 and Mid-60 indices and is eligible for the Deferred Settlement Service (SRD).ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP www.ipsos.com

SOURCE Ipsos


These press releases may also interest you

at 18:00
BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of non-hallucinogenic LSD-based therapeutics for mental disorders, today announced that the Company intends to...

at 17:45
Celonis, the global leader in Process Mining, today announced it has appointed Mark Jacobs to the role of Senior Vice President North America Sales. As the Go-to-Market leader for North America, Jacobs will work closely with new and existing...

at 17:05
DXC Technology , a leading Fortune 500 global technology services company, today announced it will participate in the following investor conferences: J.P. Morgan's Technology, Media, & Telecom 2024 Conference ? Raul Fernandez, President and CEO, is...

at 17:05
Intercontinental Exchange, Inc. ("ICE") announced today that it is commencing a private exchange offer (the "Exchange Offer") with respect to the outstanding 3.625% Senior Notes due 2028 (the "BK Notes") issued by Black Knight InfoServ, LLC, a...

at 17:00
Spyre Therapeutics, Inc. (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for the treatment of Inflammatory Bowel...

at 17:00
Sentynl...



News published on and distributed by: